EP2217213
ORALLY DISINTEGRATIVE DOSAGE FORM
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
29.10.2008EP published:
24.5.2017EP application number:
08844404.7
EPO information:
European Patent Register
Max expiry date:
28.10.2028
Title:
ORALLY DISINTEGRATIVE DOSAGE FORM
Timeline
Today
29.10.2008EP application
24.5.2017EP Publication
Owner
Name:
Johnson & Johnson Consumer Inc.Address:
199 Grandview Road, 08558, Skillman, NJ, US
Inventor
Name:
BUNICK, FrankAddress:
RandolophNJ, US
Name:
LUBER, JosephAddress:
QuakertownPA, US
Priority
Number:
983973 PDate:
31.10.2007Country:
US
Classification
Categories:
A61K 9/20